Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-000384)

Filing Details

Accession Number:: 0001209191-15-000384
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-01-02 21:30:27
Reporting Period:: 2014-12-30

Filing Date:: 2015-01-02
Accepted Time:: 2015-01-02 21:30:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1114220	Keryx Biopharmaceuticals Inc	KERX	Pharmaceutical Preparations (2834)	134087132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251213	Ron Bentsur	C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-12-30	200,000	$14.11	717,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Reflects the weighted average sale price. The range of prices for such transaction is $14.00 to $14.29.
Includes 26,070 shares of restricted stock. In addition, Mr. Bentsur holds stock options to purchase up to 1,002,932 shares of Keryx common stock.